Literature DB >> 20349908

Bilateral juvenile choroidal neovascularization associated with Best's vitelliform dystrophy: observation versus photodynamic therapy.

Francesco Viola1, Edoardo Villani, Chiara Mapelli, Giovanni Staurenghi, Roberto Ratiglia.   

Abstract

The authors recently observed a boy with bilateral choroidal neovascularization associated with Best's disease and compared the outcome of photodynamic therapy in one eye with the natural history of the untreated fellow eye. The final outcome of photodynamic therapy was inactive choroidal neovascularization, which seemed to be enveloped by the retinal pigment epithelium. The final appearance of the treated lesion was similar to the natural evolution of choroidal neovascularization in the untreated fellow eye. Copyright (c) 2010, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20349908     DOI: 10.3928/01913913-20100308-14

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  4 in total

1.  Choroidal neovascularization in 36 eyes of children and adolescents.

Authors:  P Rishi; A Gupta; E Rishi; B J Shah
Journal:  Eye (Lond)       Date:  2013-07-26       Impact factor: 3.775

2.  Choroidal neovascularization in 111 eyes of children and adolescents.

Authors:  Pukhraj Rishi; Rekha Priya Kalluri Bharat; Ekta Rishi; Muna Bhende; Jyotirmay Biswas; Arshee Ahmed; Sridharan Sudharshan
Journal:  Int Ophthalmol       Date:  2021-08-23       Impact factor: 2.031

3.  Intravitreal bevacizumab in choroidal neovascularization associated with Best's vitelliform dystrophy.

Authors:  Subrata Mandal; Subijay Sinha; Pradeep Venkatesh; Nagender Vashisht
Journal:  Indian J Ophthalmol       Date:  2011 May-Jun       Impact factor: 1.848

4.  Choroidal Neovascularization in Pediatric Patients: Analysis of Etiologic Factors, Clinical Characteristics and Treatment Outcomes.

Authors:  Ting Zhang; You Wang; Wenjia Yan; Yafen Liu; Jinglin Lu; Limei Sun; Songshan Li; Li Huang; Zhaotian Zhang; Xiaoyan Ding
Journal:  Front Med (Lausanne)       Date:  2021-11-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.